NATR at a glance
NATURES SUNSHINE PRODUCTS INC (NATR, SEC CIK 275053) filed its latest 10-K annual report on March 10, 2026, a 10-Q quarterly report on August 6, 2026, an 8-K current report on August 6, 2026 and Form 4 insider filings as recently as September 15, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), NATURES SUNSHINE PRODUCTS INC (NATR) reported revenue of $480.1 million (up 5.7% from FY2024) and net income of $19.5 million. Diluted EPS was $1.06.
- As of June 30, 2026, 25 institutional investment managers tracked by SignalX reported holding NATURES SUNSHINE PRODUCTS INC (NATR) shares worth $106.8 million in 13F-HR filings.
- The most recent insider open-market purchase reported on Form 4 was by PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. on August 17, 2026 of 20,000 shares at $14.69 per share.
- In the last 90 days, NATR insiders reported 14 open-market purchases ($2.6M) and 0 open-market sales ($0) on Form 4, a net purchase of $2.6M.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $480.1M
- +5.7% vs prior year
- Insiders · 90 days
- 14 buys · 0 sells
- Net +$2.6M
- 13F holders
- 25 funds
- $106.8M · −1 vs prior quarter
- Latest 8-K
- Aug 6, 2026
- Item 2.02 · Item 5.02
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Jun 30, 2026
Management Discussion & Analysis
- Revenue $117.0M, up 1.9% YoY from $114.8M; local-currency growth 3.8%
- Gross margin 73.7% vs 71.7%; operating margin 4.7% vs 3.7%
- Best region Europe, sales up 4.4% to approximately $[not stated]; Latin America and Other worst, down 0.5%
- Net income $3.5M, down 35.9% YoY from $5.5M; other expense $0.1M vs $3.3M income
- Tariffs expected to adversely affect costs during the remainder of 2026; Ukraine conflict expected to impact business foreseeable future
Risk Factors
- New trade-controls risk triggered by BIS and OFAC voluntary disclosures from internal investigation
- OFAC self-disclosure remains pending, with potential fines or penalties
- Potential violations represented less than 1% of net revenue in each of the last three fiscal years
- Regulatory exposure includes possible sanctions, export-license requirements, and mandated business-practice changes
- Compliance controls may not prevent violations by employees, suppliers, manufacturers, or agents
AI summary of the NATR 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 2.02: Results of Operations and Financial Condition
- Press release contains non-GAAP financial measures for fiscal year 2026 results
- Management views adjusted metrics as useful for period-to-period comparability
Item 5.02: Departure/Appointment of Directors or Principal Officers
- Ruth Perkins appointed Executive Vice President and CFO effective September 1, 2026, replacing no stated incumbent
- Finance leadership scope includes planning, accounting, treasury, tax, audit, investor relations, and reporting
Item 5.02: Departure/Appointment of Directors or Principal Officers
- CFO L. Shane Jones resigns effective June 5, 2026, creating near-term finance leadership transition risk
- Company cites no disagreement over financial reporting, accounting policies, procedures, estimates, or judgments
Item 2.02: Results of Operations and Financial Condition
- Press release contains fiscal 2026 results and non-GAAP metrics
- Non-GAAP measures intended to improve period-to-period comparability
Item 5.02: Departure/Appointment of Directors or Principal Officers
- Shareholders approved the 2026 Stock Incentive Plan, effective May 6, 2026
- Plan reserves up to 1,500,000 common shares for employee, officer, consultant, and director awards
Item 5.07: Submission of Matters to a Vote of Security Holders
- All 8 director nominees elected, with 13.7M–13.8M votes for each
- Executive compensation advisory vote approved, with 11,288,205 votes for and 779,056 against
AI summaries of NATR 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for NATR
Don't miss the next NATR filing
- Alerts as it files. A push when NATR files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut NATR, by share count.
- Ask anything. An AI agent that reads every NATR filing and answers with sources.
NATR alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Perkins Ruth Ann | A | Sep 2, 2026 | 36,049 | - |
| Perkins Ruth Ann | A | Sep 2, 2026 | 39,384 | - |
| Lanoy Jonathan David | A | Sep 1, 2026 | 7,210 | - |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | Buy | Aug 17, 2026 | 20,000 | $14.69 |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | Buy | Aug 10, 2026 | 876 | $15.64 |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | Buy | Aug 10, 2026 | 16,928 | $15.80 |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | Buy | Aug 10, 2026 | 10,000 | $16.01 |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | Buy | Aug 10, 2026 | 13,072 | $15.78 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $454.4M | $480.1M |
| Gross Profit | - | $324.7M | $347.7M |
| Operating Income | - | $20.1M | $24.7M |
| Net Income | - | $7.7M | $19.5M |
| Gross Margin | - | 71.5% | 72.4% |
| Op. Margin | - | 4.4% | 5.2% |
| Net Margin | - | 1.7% | 4.1% |
| Balance Sheet | |||
| Total Assets | $249.8M | $240.9M | $261.1M |
| Equity | $159.5M | $161.0M | $161.6M |
| ROE | - | 4.8% | 12.1% |
| Per Share | |||
| EPS | - | $0.40 | $1.06 |
| Cash Flow | |||
| Operating CF | - | $25.3M | $35.3M |
| CapEx | - | $11.0M | $6.5M |
Source: XBRL data in NATURES SUNSHINE PRODUCTS INC (NATR)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate NATR share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 25 | $106.8M |
| Q1 2026 | 26 | $117.8M |
| Q4 2025 | 23 | $103.3M |
| Q3 2025 | 22 | $77.7M |
| Q2 2025 | 22 | $63.4M |
| Q1 2025 | 20 | $39.7M |
| Q4 2024 | 15 | $40.1M |
| Q3 2024 | 12 | $25.9M |
- Vanguard Portfolio Management LLC+172.6K (+148%)
- Dimensional Fund Advisors+28.2K (+3%)
- FMR LLC (Fidelity)+27.1K (+141%)
- Goldman Sachs Group+14.6K (+22%)
- Vanguard Capital Management LLC+7.6K (+1%)
- BlackRock−75.4K (-7%)
- AQR Capital Management−66.7K (-49%)
- Morgan Stanley−32.5K (-12%)
- Two Sigma Investments−23.7K (-15%)
- Ameriprise Financial−15.4K (-14%)
- Millennium Management+16.4K
- Citadel Advisors LLC−43.7K
- U.S. Bancorp−51
Source: 13F-HR filings on SEC EDGAR (aggregated from 165 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
NATR filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-Q quarterly reports
8-K current reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Sep 15, 2026 | - | - | - |
| 4 | Sep 3, 2026 | - | - | - |
| 4 | Aug 19, 2026 | - | - | - |
| 4 | Aug 10, 2026 | - | - | - |
| 10-Q | Aug 6, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Aug 6, 2026 | - | Analysis | - |
| 4 | Jun 29, 2026 | - | - | - |
| 4 | Jun 15, 2026 | - | - | - |
| 4 | Jun 11, 2026 | - | - | - |
| 4 | Jun 3, 2026 | - | - | |
| 4 | May 22, 2026 | - | - | |
| 4 | May 20, 2026 | - | - | |
| 4 | May 19, 2026 | - | - | |
| 4 | May 19, 2026 | - | - | |
| 4 | May 19, 2026 | - | - | |
| 4 | May 19, 2026 | - | - | |
| 4 | May 19, 2026 | - | - | |
| 4 | May 19, 2026 | - | - | |
| 4 | May 19, 2026 | - | - | |
| 4 | May 19, 2026 | - | - | |
| 4 | May 19, 2026 | - | - | |
| 4 | May 19, 2026 | - | - | |
| 4 | May 19, 2026 | - | - | |
| 4 | May 19, 2026 | - | - | |
| 4 | May 19, 2026 | - | - |
Related Health Care companies
- AARD · Aardvark Therapeutics, Inc.Pharmaceutical Preparations
- ABT · Abbott LaboratoriesPharmaceutical Preparations
- ABBV · AbbVie IncPharmaceutical Preparations
- ABEO · ABEONA THERAPEUTICS INC.Pharmaceutical Preparations
- ACAD · ACADIA PHARMACEUTICALS INCPharmaceutical Preparations
- ACRS · Aclaris Therapeutics, Inc.Pharmaceutical Preparations
- ACTU · ACTUATE THERAPEUTICS, INC.Pharmaceutical Preparations
- ADCT · ADC Therapeutics SAPharmaceutical Preparations
NATR SEC filings: frequently asked questions
Are NATR insiders buying or selling?
In the last 90 days, NATURES SUNSHINE PRODUCTS INC (NATR) officers, directors and 10% owners reported 14 open-market purchases worth $2.6 million by 1 insider and no open-market sales on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold NATR stock?
As of June 30, 2026, the largest NATURES SUNSHINE PRODUCTS INC (NATR) holders among the 13F filers tracked by SignalX were BlackRock ($21.6 million), Dimensional Fund Advisors ($20.1 million), Vanguard Capital Management LLC ($13.2 million), Renaissance Technologies LLC ($11.5 million), State Street Corp ($7.1 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was NATR's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), NATURES SUNSHINE PRODUCTS INC (NATR) reported revenue of $480.1 million (up 5.7% from FY2024) and net income of $19.5 million. Diluted EPS was $1.06. The figures come from the XBRL data in the 10-K.
What did NATR report in its latest 8-K?
NATURES SUNSHINE PRODUCTS INC (NATR) filed an 8-K on August 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition) and Item 5.02 (Departure/Appointment of Directors or Principal Officers). Press release contains non-GAAP financial measures for fiscal year 2026 results.
What are the latest NATR SEC filings?
NATURES SUNSHINE PRODUCTS INC (NATR) filed its latest 10-K annual report on March 10, 2026, a 10-Q quarterly report on August 6, 2026, an 8-K current report on August 6, 2026 and a Form 4 insider filing on September 15, 2026.
What is NATR's SEC CIK number?
NATURES SUNSHINE PRODUCTS INC (NATR)'s SEC Central Index Key (CIK) is 275053. EDGAR lists every NATR filing under that number.
Ask anything about NATR
The research agent reads NATR's filings, financials, insider trades and 13F holders, then answers with sources.